Revista Espanola de Quimioterapia

Article	Citations
Insights for COVID-19 in 2023	50
New variants of SARS-CoV-2	48
Pharmacological treatment of COVID-19: an opinion paper	45
Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination	36
Temporary hospitals in times of the COVID pandemic. An example and a practical view	36
Monkeypox in humans: a new outbreak	30
Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?	28
Aspiration pneumonia	23
COVID-19: Impact on prescribing and antimicrobial resistance	20
Real-life use of remdesivir in hospitalized patients with COVID-19	20
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting	18
Dalbavancin	15
Post-COVID syndrome: A reflection and opinion paper	14
Recommendations on the use of azole antifungals in hematology-oncology patients	12
Respiratory co-and superinfections in COVID-19	11
High level of medication regimen complexity index correlate with worse quality of life in people living with HIV	11
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain	10
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers	10
Antiviral drugs against SARS-CoV-2	10
New definitions of susceptibility categories EUCAST 2019: clinic application	10
Ceftazidime-avibactam	10
Vaccine against COVID-19	9
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences	9
Booster or additional vaccination doses in patients vaccinated against COVID-19	8
The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19	8

Cefiderocol	8
Sexually transmitted infections in Spain: Current status	8
Antimicrobial stewardship programs in emergency departments: how do we measure antimicrobial use? A systematic review	8
Antimicrobial resistance and One Health	8
Ceftolozane-tazobactam: When, how and why using it?	8
Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections	7
Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study	7
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies	7
Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study	7
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria	7
Experience with the use of siltuximab in patients with SARS-CoV-2 infection	7
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker	7
Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study	6
Latent tuberculosis infection: approach and therapeutic schemes	6
Emergency detection of HIV infection in patients consulting for conditions potentially related to occult infection: Initial results of the “Urgències VIHgila” program	6
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection	6
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-neg	6
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience	6
Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital	6
Recommendations for antibiotic selection for severe nosocomial infections	6
Oral antibiotic treatment of exacerbation of COPD. Beyond COVID-19	6
Impact of Staphylococcus aureus bacteremia in COVID-19 patients	6
Tedizolid: new data and experiences for clinical practice	5
Group A Streptococcus invasive infection in children: Epidemiologic changes and implications	5
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures	5
Utilization study in real clinical practice of ceftolozane/tazobactam vs aminoglycosides and/or colistin in the treatment of multirresistant or extremely resistant Pseudomonas aeruginosa	5
Diagnostic accuracy of combining C-Reactive protein and Alvarado Score among 2-to-20-year-old patients with acute appendicitis suspected presenting to Emergency Departments	5
Sepsis Code: dodging mortality in a tertiary hospital	5
Current microbiological aspects of community respiratory infection beyond COVID-19	5
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome	5
Ceftazidime-avibactam	5
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives	5
Optimized identification of microorganisms directly from positive blood cultures by MALDI-TOF to improve antimicrobial treatment	5
Impact of the implementation of a Sepsis Code Program in medical patient management: a cohort study in an Internal Medicine ward	5
Ceftobiprole: a clinical view	5
Antibacterial spectrum of cefiderocol	5
Unusual isolation of Pseudoglutamicibacter cumminsii in urine culture	5
Brain abscesses caused by anaerobic microorganisms: a systematic review	4
Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain	4
Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospit	4
Streptococcus cristatus, an infrequent cause of bacteremia and infective endocarditis. Case report and literature review	4
Mechanism of action of cefiderocol	4
Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications	4
In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals	4
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper	4
Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza	4
Implementation of the delayed antibiotic prescribing strategy. Prospective observation study in primary care	4
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper	4
Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19	4
Suppressive antibiotic treatment with dalbavancin. A case report	4

Immune treatment in COVID-19	4
Increased severity in SARS-CoV-2 infection of minorities in Spain	4
Diagnostic accuracy of procalcitonin for bacteremia in the emergency department: a systematic review	4
Respiratory consequences after COVID-19: outcome and treatment	4
Increased infections by herpes simplex virus type 1 and polymicrobials of the genital tract, in the general population of a Spanish middle city	4
Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients	4
Methicillin-resistant Staphylococcus epidermidis infectious keratitis: Clinical and microbiological profile	4
Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outb	4
Clinical implications of the genus Mycoplasma	4
Bioinformatics approaches to the study of antimicrobial resistance	4
Identificación de creencias y actitudes relacionadas con la desprescripción en pacientes VIH+ de edad avanzada: Proyecto ICARD	4
A systematic review and expert’s analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain	4
Community-acquired pneumonia: similarities and differences between European and American guidelines – A narrative review –	4
Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program	4
SARS-CoV-2 infection presenting as acute acalculous cholecystitis	4
Current treatment of nosocomial pneumonia and ventilator-associated pneumonia	4
Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses	4
Identifying the most important data for research in the field of infectious diseases: thinking on the basis of artificial intelligence	4
Overview of virus and cancer relationships. Position paper	4
Effectiveness, safety, and economic impact of the bictegravir/emtricitabine/tenofovir alafenamide regimen in real clinical practice cohort of HIV-1 infected adult patients	4
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections	3
Respiratory syncytial virus: A new era	3
COVID in Pediatric Age: an opinion paper	3
Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission	3
Expert opinion on strategies to improve vaccination coverage against seasonal influenza	3
Past and future of HIV infection. A document based on expert opinion	3
New evidence in severe pneumonia: meropenem-vaborbactam	3
Choice of influenza vaccine in people over 65 years old. Analysis of reports from international vaccination advisory committees	3
Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment	3
Impact of one year of pandemic on Spanish Intensive Care Units	3
Pseudocitrobacter anthropi sepsis in a patient with complicated urinary tract infection	3
High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife	3
Bacteremia caused by Eikenella corrodens in a patient with pelvic inflammatory disease	3
Report of sexually transmitted infections prevalence in asymptomatic pregnant women under 25 years old in Lleida, Spain	3
Real-world efficacy of switching to bictegravir/ emtricitabine/tenofovir alafenamide in pretreated patients with triple therapy containing rilpivirine	3
High-dose trivalent influenza vaccine: safety and immunogenicity	3
Variability between health areas in antibiotic consumption among pediatric outpatients of Principado de Asturias, Spain (2005-2018)	3
COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications	3
Usefulness of thoracic ultrasound for diagnosis and follow-up of pneumonia	3
Efficacy of early use of remdesivir: a systematic review of subgroup analysis	3
Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient	3
Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?	3
Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa	3
Persistence and viability of SARS-CoV-2 in primary infection and reinfections	3
Actions and attitudes on the immunized patients against SARS-CoV-2	3
The role of cefiderocol in clinical practice	3
Air pollution and health prevention: A document of reflection	3
Introduction to XI Updating Course of Antimicrobials and Infectious Diseases	3
Value of syndromic panels in the management of severe community-acquired pneumonia	3
Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort	3
Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis	2
Comparison of quality of life in patients living with HIV infection through pharmaceutical care according to CMO methodology vs. conventional follow-up. MAS-VIH project	2
New evidence in severe pneumonia: imipenem/ cilastatin/relebactam	2
Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis	2
Real-life experience of hepatitis C treatment in a Spanish prison	2
Management of hyperinflammation in COVID-19 patients	2
New trends in antifungal treatment: What is coming up?	2
Usefulness of MALDI-TOF and REP-PCR against PFGE for the epidemiological study of Acinetobacter baumannii	2
Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases	2
Successful management of remdesivir extravasation	2
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project	2
Use of clinical vignettes to screen general practitioners who can participate in a clinical trial about stopping antibiotic treatment when this is no longer necessary	2
Decalogue for the selection of oral antibiotics for lower respiratory tract infections	2
Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer	2
New predictive models of bacteremia in the emergency department: a step forward	2
Current situation of sepsis care in Spanish emergency departments	2
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal	2
Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital	2
Evaluation of a lateral flow immunoassay to detect CTX-M extended-spectrum β-lactamases (ESBL) directly from positive blood cultures for its potential use in Antimicrobial Stewardship programs	2
Exploring therapeutic options for mild diabetic-related foot infections: a comparative in vitro study of cefditoren versus amoxicillin/clavulanic acid	2
Ceftaroline	2
Ceftobiprole medocaril	2
Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections	2
Secondary Bordetella hinzii pneumonia in a patient with SARS-CoV-2 infection	2
The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued	2
Treatment of infections caused by carbapenemase-producing Enterobacterales	2
Ceftaroline in severe community-acquired pneumonia	2
Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?	2
Utility of the blood culture in infection of the urinary tract with fever in the elderly	2
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting	2

A systematic review on extensively drug-resistant tuberculosis from 2009 to 2020: special emphases on treatment outcomes	2
Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017	2
First case of Arcobacter cryaerophilus in paediatric age in Spain	2
Retrospective diagnosis of lymphatic tuberculosis in frozen samples using two genetic amplification methods, Xpert® MTB/RIF ULTRA and Abbott RealTime MTB Assay	2
Mycoplasma genitalium in Primary Care: Prevalence and azithromycin resistance in Santiago de Compostela Health Care Area	2
Identification of curved Gram-negative rods by MALDI-TOF mass spectrometer in a patient with Fournier ́s gangrene. A bacteremia caused by Desulfovibrio desulfuricans and Escherichia coli	2
Antimicrobial stewardship program in an Intensive Care Unit: A retrospective observational analysis of the results 15 months after its implementation	2
Shigellosis attended in the emergency department of a regional hospital in southeastern Spain: from their presence to multiresistance	2
Two cases of Prevotella oris causing serious pleuropulmonary infections	2
Urgent need for a rapid microbiological diagnosis in critically ill pneumonia	2
Nosocomial meningitis caused by ESBL- and OXA-48-producing Klebsiella pneumoniae and treated with ceftazidime-avibactam. Report of one case and review of the literature	2
Unresolved issues in the epidemiology and diagnosis of bacteremia: an opinion paper	2
Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)	2
Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina	2
Impact of Sepsis Flow Chip, a novelty fast microbiology method, in the treatment of bacteremia caused by Gram-negative bacilli	2
Time to decision in sepsis	2
Eumycetomas by Fusarium oxysporum and Madurella mycetomatis. Description of two cases and literature review	2
Global strategy in the treatment of HIV infection in 2022	2
Current approach to skin and soft tissue infections. Thinking about continuity of care	2
Microbial etiology of bacterial chronic prostatitis: systematic review	2
Evolution of adherence to hand hygiene in health care professionals in a third level hospital in relation to the SARS-CoV-2 pandemic	2
Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex™ NG&DR Assay (Seegene®) in a tertiary hospital from Madrid, Spain	2
What happened to microbiological diagnosis in 2020 beyond COVID-19?	2
Microscopy vs. molecular biology in the diagnosis of intestinal protozoal infections, is it time for a change?	2
Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort	2
RedLabRA; a Spanish Network of Microbiology Laboratories for the Surveillance of Antibiotic Resistant Microorganisms	2
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020	2
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León	2
Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis	2
Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2	2
Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus	2
Pulmonary nocardiosis after covid-19 infection: case report and literature review	2
Comparative study of the COVID-19 admissions between first and second wave in a cohort of 1,235 patients	2
Ceftolozane-tazobactam in nosocomial pneumonia	2
Treatment guidelines for multidrug-resistant Gram-negative microorganisms	2